Transforming growth factor-β1: Differential effects on multiple myeloma versus normal B cells

Blood

Volumn 87, Issue 5, 1996, Pages 1928-1938

  Urashima, Mitsuyoshi ^b   Ogata, Atsushi ^b   Chauhan, Dharminder ^b   Hatziyanni, Maria ^b   Vidriales, Maria B ^b   Dedera, Douglas A ^b   Schlossman, Robert L ^b   Anderson, Kenneth C ^a  

^a DANA FARBER CANCER INSTITUTE   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 6; RETINOBLASTOMA PROTEIN; TRANSFORMING GROWTH FACTOR BETA1;

ARTICLE; B LYMPHOCYTE; CANCER GROWTH; HUMAN; HUMAN CELL; LYMPHOCYTE PROLIFERATION; MULTIPLE MYELOMA; PRIORITY JOURNAL; PROTEIN DETERMINATION; PROTEIN PHOSPHORYLATION;

EID: 0030026437     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v87.5.1928.bloodjournal8751928     Document Type: Article

References (71)

1. Kawano M, Hirano T, Matsuda T, Taga T, Horii Y, Iwato K, Asaoku H, Tang B, Tanabe O, Tanaka H, Kuramoto A, Kishimoto T: Autocrine generation and requirement of BSF-2/IL-6 for human multiple myeloma. Nature 332:83, 1988
2. Barut BA, Zon LI, Cochran MK, Paul SR, Chauhan D, Mohrbacher A, Fingeroth J, Anderson KC: Role of interleukin-6 in the growth of myeloma derived cell lines. Leuk Res 16:951, 1992
3. Anderson KC, Jones RC, Morimoto C, Leavitt P, Barut BA: Response patterns of purified myeloma cells to hematopoietic growth factors. Blood 73:1915, 1989
4. Barut B, Chauhan D, Uchiyama H, Anderson KC: Interleukin-6 functions as an intracellular growth factor in hairy cell leukemia in vitro. J Clin Invest 92:2346, 1993
5. Urashima M, Chauhan D, Uchiyama H, Freeman GJ, Anderson KC: CD40 ligand triggered interleukin-6 secretion in multiple myeloma. Blood 85:1903, 1995
6. Westendorf JJ, Ahmann GJ, Armitage RJ, Spriggs MK, Lust JA, Greipp PR, Katzmann JA, Jelinek DF: CD40 expression in malignant plasma cells. Role in stimulation of autocrine IL-6 secretion by a human myeloma cell line. J Immunol 152:117, 1994
7. Klein B, Zhang XG, Jourdan M, Content J, Houssiau F, Aarden L, Piechaczyk M, Bataille R: Paracrine rather than autocrine regulation of myeloma-cell growth and differentiation by interleukin-6. Blood 73:517, 1989
8. Uchiyama H, Barut BA, Mohrbacher AF, Chauhan D, Anderson KC: Adhesion of human myeloma-derived cell lines to bone marrow stromal cells stimulates mterleukin-6 secretion. Blood 82:3712, 1993
9. Kim I, Uchiyama H, Chauhan D, Anderson KC: Cell surface expression and functional significance of adhesion molecules on human myeloma-derived cell lines. Br J Haematol 87:483, 1994
10. Chauhan D, Uchiyama H, Akbarali Y, Urashima M, Yamamoto K, Liebermann TA, Anderson KC: NFκB regulates multiple myeloma (MM) cell adhesion-related interleukin-6 (IL-6) transcription in bone marrow stromal cells (BMSCs). Blood 84:524a, 1994 (abstr, suppl 1)
11. Kawano M, Tanaka H, Ishikawa H, Nobuyoshi M, Iwato K, Asaoku H, Tanabe O, Kuramoto A: Interleukin-1 accelerates autocrine growth of myeloma cells through interleukin-6 in human myeloma. Blood 73.2145, 1989
12. Zhang XG, Bataille R, Jourdan M, Saeland S, Banchereau J, Mannoni P, Klein B: Granulocyte-macrophage colony-stimulating factor synergizes with interleukin-6 in supporting the proliferation of human myeloma cells. Blood 76:2599, 1990
13. Lu ZY, Zhang XG, Rodriguez C, Wijdenes J, Gu Z-J, Morel-Fournier B, Harousseau JL, Bataille R, Rossi J-F, Klein B: Interleukin-10 is a proliferation factor but not a differentiation factor for human myeloma cells Blood 85:2521, 1995
14. Assoian RK, Komoriya A, Meyers CA, Miller DM, Sporn MB: Transforming growth factor beta in human platelets: Identification of a major storage site, purification, and characterization. J Biol Chem 258:7155, 1983
15. Heinrich MC, Dooley DC, Keeble WW: Transforming growth factor β1 inhibits expression of the gene products for steel factor and its receptor (c-kit). Blood 85:1769, 1995
16. Lagneaux L, Delforge A, Dorval C, Bron D, Stryckmans P: Excessive production of transforming growth factor-β by bone marrow stromal cells in B-cell chronic lymphocytic leukemia inhibits growth of hematopoietic precursors and interleukin-6 production. Blood 82:2379, 1993
17. Battegay EJ, Raines EW, Seifert RA, Bowen-Pope DF, Ross R: TGF-β induces bimodal proliferation of connective tissue cells via complex control of an autocrine PDGF loop. Cell 63:515, 1990
18. Kehrl JH, Roberts AB, Wakefield LM, Jakowlew S, Sporn MB, Fauci AS: Transforming growth factor β is an important immunoregulatory protein for human B lymphocytes. J Immunol 137:3855, 1986
19. Kehrl JH, Taylor AS, Delsing GA, Roberts AB, Sporn MB, Fauci AS: Further studies of the role of transforming growth factor-β in human B cell function. J Immunol 143:1868, 1986
20. Derynck R, Goeddel DV, Ullrich A, Gutterman JU, Williams RD, Bringman TS, Berger WH: Synthesis of messenger RNAs for transforming growth factors α and β and the epidermal growth factor receptor by human tumors. Cancer Res 47:707, 1987
21. Lotz M, Ranheim E, Kipps TJ: Transforming growth factor β as endogenous growth inhibitor of chronic lymphocytic leukemia B cells. J Exp Med 179:999, 1994
22. Kumar A, Rogers T, Maizel A, Sharma S: Loss of transforming growth factor β1 receptors and its effects on the growth of EBV-transformed human B cells. J Immunol 147:998, 1991
23. Blomhoff HK, Smeland E, Mustafa AS, Godal T, Ohlsson R: Epstein-Barr virus mediates a switch in responsiveness to transforming growth factor, type beta, in cells of the B cell lineage. Eur J Immunol 17:299, 1987
24. Falk LA, De Benedetti F, Lohrey N, Birchenall-Roberts MC, Ellingsworth LW, Faltynek CR, Ruscetti FW: Induction of transforming growth factor β1 (TGF β1) receptor expression and TGF β1 protein production in retinoic acid-treated HL-60 cells: Possible TGF β1-mediated autocrine inhibition. Blood 77:1248, 1991
25. Shipley GD, Pittelkow MR, Wille JJ, Scott RE, Moses HL: Reversible inhibition of normal human prokeratinocyte proliferation by type β transforming growth factor-growth inhibition in serum-free medium. Cancer Res 46:2068, 1986
26. Sporn MB, Roberts AB, Wakefield LM, Assoian RK: Transforming growth factor-β: biological function and chemical structures. Science 233:532, 1986
27. Berg DJ, Lynch RG: Immune dysfunction in mice with plasmacytomas. I. Evidence that transforming growth factor-β contributes to the altered expression of activation receptors on host B lymphocytes. J Immunol 146:2865, 1991
28. Ullrich S, Zolla-Pazner S: Immunoregulatory circuits in myeloma. Clin Haematol 11:87, 1982
29. Urashima M, Hasegawa N, Kamijo M, Shishikura A, Kato Y, Hoshi Y, Akatsuka J-I, Maekawa K: Establishment of human pro-B cell line (JKB-1) and its differentiation on pre-established bone marrow stromal cell layer. Am J Hematol 46:112, 1994
30. Gartner SM, Kaplan HS: Long term culture of human bone marrow cells. Proc Natl Acad Sci USA 77:4756, 1980
31. Aizawa S, Yaguchi M, Nakao M, Toyama K, Inokuchi S, Imai T, Yasuda M, Nabeshima R, Handa H: Hematopoietic supportive function of human bone marrow stromal cell lines established by a recombinant SV40-adenovirus vector. Exp Hematol 22:482, 1994
32. Chauhan D, Kharbanda S, Uchiyama H, Urashiraa M, Fragoso R, Sen J, Kufe DW, Anderson KC: Identification of upstream signals regulating interleukin-6 gene expression during in vitro treatment of human B cells with pokeweed mitogen. Blood 84:2243, 1994
33. Urashima M, Chauhan D, Hatziyanni M, Ogata A, Hollenbaugh D, Arufo A, Anderson KC: CD40 ligand triggers interleukin-6 mediated B cell differentiation. Leuk Res (in press)
34. Hollenbaugh D, Grosmaire LS, Kullas CD, Chalupny NJ, Braesch-Andersen S, Noelle RJ, Stamenkovic I, Ledbetter JA, Aruffo A: The human T cell antigen gp39, a member of the TNF gene family, is a ligand for the CD40 receptor: Expression of a soluble form of gp39 with B cell co-stimulatory activity. EMBO J 11:4313, 1992
35. Roussel F, Garcia E, Defrance T, Peronne C, Vezzio N, Hsu DH, Kastelein R, Moore KW, Banchereau J: Interleukin 10 is a potent growth and differentiation factor for activated human B lymphocytes. Proc Natl Acad Sci USA 89:1890, 1992
36. Portier M, Zhang XG, Ursule E, Lees D, Jourdan M, Bataille R, Klein B: Cytokine gene expression in human multiple myeloma Br J Haematol 85:514, 1993
37. Matthes T, Werner-Favre C, Zubler RH: Cytokine expression and regulation of human plasma cells: Disappearance of interleukin-10 and persistence of transforming growth factor-β1. Eur J Immunol 25:508, 1995
38. Matthes T, Werner-Favre C, Tang H, Zhang X, Kindler V, Zubler RH: Cytokine mRNA expression during an in vitro response of human B lymphocytes: Kinetics of B cell tumor necrosis factor α, interleukin (IL)-6, IL-10, and transforming growth factor-β1 mRNAs. J Exp Med 178:521, 1993
39. Elias JA, Lentz V, Cummings PJ: Transforming growth factor-β regulation of IL-6 production by unstimulated and IL-1-stimulated human fibroblasts. J Immunol 146:3437, 1991
40. Gimble JM, Hudson J, Henthom J, Hua XX, Burstein SA: Regulation of interleukin-6 expression in murine bone marrow stromal cells. Exp Hematol 19:1055, 1991
41. McGee DW, Beagley KW, Aicher WK, McGhee JR: Transforming growth factor β and IL-1β act in synergy to enhance IL-6 secretion by the intestinal epithelial cell line, IEC-6. J Immunol 151:970, 1993
42. McGee DW, Beagley KW, Aicher WK, McGhee JR: Transforming growth factor-β enhances interleukin-6 secretion by intestinal epithelial cells. Immunology 77.7, 1992
43. Gautam SC, Noth CJ, Niewenhuis LM, Janakiraman N, Kim JS, Chopp M: Transforming growth factor-β (TGF β1) potentiates IL1α-induced IL-6 mRNA and cytokine production in a human astrocytoma cell line. Oncol Res 5:423, 1993
44. Campos SP, Wang Y, Koj A, Baumann H: Divergent transforming growth factor-β effects on IL-6 regulation of acute phase plasma proteins in rat hepatoma cells. J Immunol 151:7128, 1993
45. Shalaby MR, Waage A, Espevik T: Cytokine regulation of interleukin 6 production by human endothelial cells. Cell Immunol 121:372, 1989
46. Rieckmann P, D'Alessandro F, Nordan RP, Fauci AS, Kehrl JH: IL-6 and tumor necrosis factor-α. Autocrine and paracrine cytokines involved in B cell function. J Immunol 146:3462, 1991
47. Zhao XZ, Frist WH, Yeoh TK, Miller GG: Expression of cytokine genes in human cardiac allografts: Correlation of IL-6 and transforming growth factor-β (TGF-β) with histological rejection. Clin Exp Immunol 93:448, 1993
48. Uchiyama H, Barut BA, Chauhan D, Cannistra SA, Anderson KC: Characterization of adhesion molecules on human myeloma cell lines. Blood 80:2306, 1992
49. Moses HL, Yang EY, Pietenpol JA: TGF-β stimulation and inhibition of cell proliferation: New mechanistic insights. Cell 63:245, 1990
50. Pietenpol JA, Stein RW, Moran E, Yaciuk P, Schlegel R, Lyons RM, Pittelkow MR, Munger K, Howley PM, Moses HL: TGF α1 inhibition of c-myc transcription and growth in keratinocytes is abrogated by viral transforming proteins with pRB binding domains. Cell 61:777, 1990
51. Hamel PA, Phillips RA, Muncaster M, Gallie BL: Speculations on the roles of RB1 in tissue-specific differentiation, tumor infiltration, and tumor progression. FASEB J 7:846, 1993
52. Laiho M, DeCaprio JA, Ludlow JW, Livingston DM, Massague J: Growth inhibition by TGF-β linked to suppression of retinoblastoma protein phosphorylation. Cell 62:175, 1990
53. Corradini P, Inghirami G, Astolfi M, Ladetto M, Voena C, Ballerini P, Gu W, Nilsson K, Knowles DM, Boccadoro M, Pileri A, Dalla-Favera R: Inacuvation of tumor suppressor genes, p53 and RBl, in plasma cell dyscrasias. Leukemia 8:758, 1994
54. Dao DD, Sawyer JR, Epstein J, Hoover RG, Barlogie B, Tricot G: Deletion of the retinoblastoma gene in multiple myeloma. Leukemia 8:1280, 1994
55. Kehrl JH, Wakefield LM, Roberts AB, Jakowlew S, Alvarez-Mon M, Derynck R, Sporn MB, Fauci AS: Production of transforming growth factor β by human T lymphocytes and its potential role in the regulation of T cell growth. J Exp Med 163:1037, 1986
56. Ranges GE, Figari IS, Espevik T, Palladino MA Jr: Inhibition of cytotoxic T cell development by transforming growth factor-β and reversal by tumor necrosis factor-α. J Exp Med 166:991, 1987
57. Stach RM, Rowley DA: A first or dominant immunization. II. Induced iminunoglobulin carries transforming growth factor-β and suppresses cytolytic T cell responses to unrelated alloantigens. J Exp Med 178:841, 1993
58. Rook AH, Kehrl JH, Wakefield LM, Roberts AB, Sporn MB, Burlington DB, Lane HC, Fauci AS: Effects of transforming growth factor β on the functions of natural killer cells: Depressed cytolytic activity and blunting of interferon responsiveness. J Immunol 136:3916, 1986
59. Kasid A, Bell GI, Director EP: Effects of transforming growth factor-β on human lymphokine-activated killer cell precursors. J Immunol 141:690, 1988
60. Nelson BJ, Ralph P, Green SJ, Nacy CA: Differential susceptibility of activated macrophage cytotoxic effector reactions to the suppressive effects of transforming growth factor-β1. J Immunol 146:1849, 1991
61. Espinoza-Delgado I, Bosco MC, Musso T, Mood K, Ruscetti FW, Longo DL, Varesio L: Inhibitory cytokine circuits involving transforming growth factor-β, interferon-γ, and interleukin-2 in human monocyte activation. Blood 83:3332, 1994
62. Huchet R, Bruley-Rosset M, Mathiot C, Grandjon D, Halle-Pannenko O: Involvement of IFN-γ and transforming growth factor-β in graft-vs-host reaction-associated immunosuppression. J Immunol 150:2517, 1993
63. Waltenberger J, Wanders A, Fellstrom B, Miyazono K, Heldin C-H, Funa K: Induction of transforming growth factor-β during cardiac allograft rejection. J Immunol 151-1147, 1993
64. Kekow J, Wachsman W, McCutchan A, Gross WL, Zachariah M, Carson DA, Lotz M: Transforming growth factor-β and suppression of humoral immune responses in HIV infection. J Clin Immunol 87:1010, 1991
65. Niitsu Y, Urushizaki Y, Koshida Y, Terui K, Mahara K, Kohgo Y, Urushizaki I: Expression of the TGF-β gene in adult T cell leukemia. Blood 71:2633, 1988
66. Shull MM, Ormsby I, Kier AB, Pawlowski S, Diebold RJ, Yin M, Allen R, Sidman C, Proetzel G, Calvin D, Annunziata N, Doetschman T: Targeted disruption of the mouse transforming growth factors-β1 gene results in multifocal inflammatory disease. Nature 359:693, 1992
67. Kulkarni AB, Huh CG, Becker D, Geiser A, Lyght M, Flanders KC, Roberts AB, Sporn MB, Ward JM, Karlsson S: Transforming growth factor β1 null mutation in mice causes excessive inflammatory response and early death. Proc Natl Acad Sci USA 90:770, 1993
68. Hines KL, Kulkarni AB, McCarthy JB, Tian H, Ward JM, Christ M, McCartney-Francis NL, Furcht LT, Karlsson S, Wahl SM: Synthetic fibronectin peptides interrupt inflammatory cell infiltration in transforming growth factor β1 knockout mice. Proc Natl Acad Sci USA 91:5187, 1994
69. Ullrich S, Zolla-Pazner S: Immunoregulatory circuits in myeloma. Clin Haematol 11:87, 1982
70. Jacobson DR, Zolla-Panzner S: Immunosuppression and infection in multiple myeloma. Semin Oncol 13:282, 1986
71. Arteaga CL, Hurd SD, Winnier AR, Johnson MD, Fendly BM, Forbes JT: Anti-transforming growth factor (TGF)-β anti-bodies inhibit breast cancer cell tumorigenicity and increase mouse spleen natural killer cell activity. J Clin Invest 92:2569, 1993